Eagle Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Accumulated Amortization
Eagle Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Accumulated Amortization of $27.38 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2023-08-09
- 2023-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $27.38M.
- 2023-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $21.91M.
- 2022-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $16.46M.
- 2022-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $10.96M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2023-06-30 | $27.38M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $21.91M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $16.46M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $10.96M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $7.28M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $5.81M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $13.18M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $12.30M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $11.60M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $10.89M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $10.18M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $9.52M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $8.85M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $8.18M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $7.52M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $6.89M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $6.26M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $5.63M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $6.28M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $5.68M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $5.08M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $4.43M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.76M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $3.08M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $2.37M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.66M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $948.00K 10-K · filed 2018-02-26 | |
| 2016-09-30 | $461.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $260.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $948.00K 10-Q · filed 2017-05-08 | $104.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 |